United States · FDA National Drug Code directory
Carteolol Hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 61314-238_c89793f0-318b-4481-8fc0-e9cb0dcc5244
- Product NDC
- 61314-238
- Form
- SOLUTION
- Composition / generic term
- Carteolol Hydrochloride
- Labeler
- Sandoz Inc
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20000105
- Source listing expiry
- 20261231
Source-listed ingredients
- CARTEOLOL HYDROCHLORIDE — 10 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 5 mL in 1 BOTTLE, PLASTIC (61314-238-05) · 61314-238-05
- 10 mL in 1 BOTTLE, PLASTIC (61314-238-10) · 61314-238-10
- 15 mL in 1 BOTTLE, PLASTIC (61314-238-15) · 61314-238-15
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →